DNA damage checkpoint dynamics drive cell cycle phase transitions

Hui Chao(University of North Carolina at Chapel Hill), Cere E. Poovey(University of North Carolina at Chapel Hill), Ashley A. Privette(University of North Carolina at Chapel Hill), Gavin D. Grant(University of North Carolina at Chapel Hill), Hui Yan Chao(University of North Carolina at Chapel Hill), Jeanette Gowen Cook(University of North Carolina at Chapel Hill), Jeremy E. Purvis(University of North Carolina at Chapel Hill)
bioRxiv (Cold Spring Harbor Laboratory)
May 12, 2017
Cited by 5Open Access
Full Text

Abstract

ABSTRACT DNA damage checkpoints are cellular mechanisms that protect the integrity of the genome during cell cycle progression. In response to genotoxic stress, these checkpoints halt cell cycle progression until the damage is repaired, allowing cells enough time to recover from damage before resuming normal proliferation. Here, we investigate the temporal dynamics of DNA damage checkpoints in individual proliferating cells by observing cell cycle phase transitions following acute DNA damage. We find that in gap phases (G1 and G2), DNA damage triggers an abrupt halt to cell cycle progression in which the duration of arrest correlates with the severity of damage. However, cells that have already progressed beyond a proposed “commitment point” within a given cell cycle phase readily transition to the next phase, revealing a relaxation of checkpoint stringency during later stages of certain cell cycle phases. In contrast to G1 and G2, cell cycle progression in S phase is significantly less sensitive to DNA damage. Instead of exhibiting a complete halt, we find that increasing DNA damage doses leads to decreased rates of S-phase progression followed by arrest in the subsequent G2. Moreover, these phase-specific differences in DNA damage checkpoint dynamics are associated with corresponding differences in the proportions of irreversibly arrested cells. Thus, the precise timing of DNA damage determines the sensitivity, rate of cell cycle progression, and functional outcomes for damaged cells. These findings should inform our understanding of cell fate decisions after treatment with common cancer therapeutics such as genotoxins or spindle poisons, which often target cells in a specific cell cycle phase.


Related Papers

No related papers found

Powered by citation graph analysis